AI can aid healthcare, doctors must lead decisions, say experts

1. At a Glance

• AI is now integral to healthcare delivery (diagnosis, treatment automation), but expert consensus holds that clinical judgement, accountability, and final decision-making must remain with human doctors, not algorithms [5].
• India has simultaneously built formal AI-health governance — SAHI (Strategy for AI in Healthcare in India) and BODH (Benchmarking Open Data Platform for Health AI), launched 17 February 2026 [1].
• Aligns with WHO's 2021 global ethics guidance on AI in health, built around six core principles including human autonomy and accountability [3].
• Relevant for Prelims (schemes/bodies/dates) and Mains GS-II/III (health governance, ethics of technology).

2. Why in the News

• A webinar, "The Future Doctor: Balancing Clinical Experience with Technology," organised by SRM Institute of Science and Technology with The Hindu, held ahead of publication on 30 August 2026 (Chennai print edition, p.13) [5].
• Panellists — Dr. R. Jayanthi (Dean, SRM Medical College Hospital and Research Centre), Dr. Vivek N (Dean, Dental, SRM Kattankulathur Dental College), Ritubhan Gautam (Head–Global Health, Deep Tek.ai), Dr. K. Ganapathy (Hon. Distinguished Professor, IIM Jammu) — argued AI must support, not replace, clinical decision-making [5].

3. Background & Evolution

• WHO first issued "Ethics and governance of artificial intelligence for health" guidance in 2021, following 18 months of expert deliberation across ethics, law, digital technology and human rights [3].
• WHO followed up in January 2024 with guidance specifically on large multi-modal models (LMMs) in healthcare, offering 40+ recommendations for governments, tech companies and providers [4].
• India's regulatory track: AI-enabled medical devices are governed under the existing Medical Devices Rules, 2017, administered by the Central Drugs Standard Control Organisation (CDSCO) [1].
• India joined the HealthAI Global Regulatory Network (GRN) as a "pioneer country," a global consortium of health regulators on safe AI use [1].
• SAHI and BODH were launched at the India AI Impact Summit, 17 February 2026 [1].

4. Core Static Facts

Item	Detail
WHO guidance document	Ethics and governance of artificial intelligence for health (2021) [3]
WHO's 6 core AI-health principles	Protect autonomy; promote well-being/safety/public interest; ensure transparency & explainability; foster responsibility & accountability; ensure inclusiveness & equity; promote sustainability [3]
WHO follow-up guidance	Large multi-modal models (LMMs), released 18 January 2024 [4]
Indian regulator for AI medical devices	CDSCO, under Medical Devices Rules, 2017 [1]
India's national AI-health framework	SAHI — Strategy for AI in Healthcare in India [1]
Companion data platform	BODH — Benchmarking Open Data Platform for Health AI [1]
Launch event	India AI Impact Summit, 17 Feb 2026 [1]
Global regulator network	HealthAI Global Regulatory Network (GRN); India is a pioneer member [1]
News hook institution	SRM Institute of Science and Technology, Chennai (webinar host) [5]

5. Multi-Dimensional Analysis

Scientific/Technological

• AI is being used to automate multiple stages of diagnosis and treatment workflows, per Dr. Vivek's remarks [5].
• WHO flags LMMs (generative AI) as a fast-growing but higher-risk category needing distinct governance [4].

Ethical/Governance

• Core tension: AI as a decision-support tool vs. risk of doctors "outsourcing" clinical responsibility, as warned by Dr. Ganapathy [5].
• WHO's principles of accountability and human oversight directly map onto this debate — responsibility must stay traceable to a human [3].
• Need for a "verification reflex" among medical students so AI-generated output does not erode critical thinking, per Dr. Jayanthi [5].

Administrative/Regulatory

• India's approach layers a device-level regulatory pathway (CDSCO/Medical Devices Rules) with a broader ethical framework (SAHI) — dual-track governance [1].
• International coordination via GRN membership signals movement toward harmonised, cross-border AI-health regulatory standards [1].

Social

• Equity concerns: WHO explicitly lists "inclusiveness and equity" as a core principle, relevant to unequal AI-diagnostic access across urban/rural India [3].
• Medical education must adapt — AI literacy is now framed as a required competency for future doctors [5].

6. Recent Developments (last 12-18 months)

• 18 January 2024 — WHO released ethics/governance guidance specifically for large multi-modal generative AI models in health [4].
• 17 February 2026 — India launched SAHI and BODH at the India AI Impact Summit [1].
• India recognised as a "pioneer country" in the HealthAI Global Regulatory Network [1].
• 30 August 2026 — SRM Institute/The Hindu webinar on balancing AI and clinical judgement in future doctors [5].

7. Prelims Hooks

• WHO's foundational AI-health ethics guidance was published in 2021 after 18 months of expert deliberation [3].
• WHO identifies six core principles for AI in health, including "protect autonomy" and "foster responsibility and accountability" [3].
• WHO's guidance on large multi-modal models (LMMs) in health was released on 18 January 2024 [4].
• In India, AI-enabled medical devices fall under the Medical Devices Rules, 2017, regulated by CDSCO [1].
• India's national AI-in-healthcare framework is called SAHI (Strategy for AI in Healthcare in India) [1].
• The companion data-benchmarking platform is called BODH (Benchmarking Open Data Platform for Health AI) [1].
• SAHI and BODH were launched at the India AI Impact Summit on 17 February 2026 [1].
• India joined the HealthAI Global Regulatory Network (GRN) as a pioneer member country [1].
• The Hindu-reported webinar "The Future Doctor: Balancing Clinical Experience with Technology" was organised by SRM Institute of Science and Technology [5].
• Dr. K. Ganapathy, a panellist, holds positions at IIM Jammu, Tamil Nadu Dr. M.G.R. Medical University, and the National Academy of Medical Sciences [5].

8. Mains Relevance

• GS-II: Governance — issues relating to health, ethics of technology adoption, government policies for vulnerable sections/education.
• GS-III: Science & Technology — developments in AI and their applications/effects in everyday life; Health.
• Possible question stems: 1. "AI can augment but not replace clinical judgement in healthcare." Discuss with reference to India's regulatory approach to AI-enabled medical devices. (GS-III, 15 marks) 2. Examine the ethical principles that should govern the deployment of artificial intelligence in public healthcare systems, referencing WHO's 2021 guidance. (GS-II/IV, 10 marks) 3. Critically evaluate India's dual-track strategy of device-level regulation and ethical frameworks (SAHI) in governing AI in healthcare. (GS-III, 15 marks)

9. Related Topics to Study Next

• CDSCO & Medical Devices Rules, 2017 — the statutory backbone regulating AI medical devices in India.
• National Digital Health Mission (ABDM) — India's broader digital health infrastructure AI interacts with.
• WHO's Global Strategy on Digital Health 2020–2025 — parent policy context for AI-health guidance.
• Data protection & DPDP Act, 2023 — governs patient data used to train/operate health AI.
• NITI Aayog's National Strategy for Artificial Intelligence (#AIforAll) — India's overarching AI policy umbrella.
• Medical Council/NMC regulations on telemedicine — parallel doctor-accountability framework relevant to AI-assisted care.
• India AI Impact Summit — the broader summit platform where SAHI/BODH were unveiled.

10. Common Errors / Trap Areas

• Do not confuse SAHI (Strategy for AI in Healthcare in India) with similarly-named international frameworks — SAHI is India-specific and health-sector-specific.
• AI medical devices are regulated under the Medical Devices Rules, 2017 via CDSCO, not a standalone "AI Act" — India has no dedicated AI law as of this note.
• WHO's 2021 guidance and its 2024 LMM-specific guidance are two distinct documents — do not conflate general AI-health ethics with the generative-AI/LMM addendum.
• The webinar itself is an institutional/media event, not a government policy announcement — do not cite it as a regulatory action.
• Note the panellists' correct institutional affiliations (e.g., Dr. Ganapathy is linked to IIM Jammu, not a medical college alone) — mixing these up is a common trap in "who said what, where" questions.